Dr. Axel Hamann

Member of the Executive Board

Born 1974.

1994 - 1996: Studies of Law and Economics, University Bayreuth, Germany
1996 - 1999: Julius-Maximilians-University of Wuerzburg, Germany, First State Examination, Law
2000 - 2002: Doctor of Philosophy, PhD (Banking, Corporate, Finance & Securities Law), University of Cologne
2001 - 2003: Higher Regional Court OLG Duesseldorf, Second State Examination, Law
2008 - 2010: Executive MBA (Finance, General Management), Kellog School of Management, Nortwestern University (USA)
2017: Harvard Business School, Driving Corporate Performance, Senior Executive Program

2003 - 2005: Senior Associate, Hengeler Mueller
2005 - 2007: Head of Legal M&A, Bayer AG
2007 - 2010: Executive Board Support, Finance
2010 - 2014: CEO and CFO, Bayer Turkey
2014 - 2015: Global Project lead IPO and Carve-out "Covestro"
2016 - 2018: Head of Bayer Business Consulting
2019 - 2020: Project lead of the restructuring program "Bayer 2022"
2020 - 2022: CFO, Bayer Pharmaceuticals
2023 - 2025: Head of Internal Audit & Risk Management, Head of Global M&A, Bayer AG
since May 1, 2025: Member of the Executive Board, thyssenkrupp AG